4921.T
Fancl Corporation [4921.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4921.T Stock Summary
Top 10 Correlated ETFs
4921.T
Top 10 Correlated Stocks
4921.T
In the News
4921.T Financial details
Company Rating
Buy
Market Cap
239.01B
Income
7.56B
Revenue
108.06B
Book val./share
649.83
Cash/share
304.88
Dividend
34
Dividend %
1.44%
Employees
1.28K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
43.38
Forward P/E
-
PEG
259.02
P/S
2.68
P/B
3.69
P/C
5.89
P/FCF
-
Quick Ratio
1.93
Current Ratio
2.48
Debt / Equity
0.13
LT Debt / Equity
-
-
-
EPS (TTM)
62.53
EPS next Y
-
EPS next Q
-
EPS this Y
-33.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-9.79%
Revenue last 5Y
-3.3%
Revenue Q/Q
8.96%
EPS Q/Q
23.95%
-
-
-
-
SMA20
-8.4%
SMA50
-18.78%
SMA100
-15.24%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
9%
ROC
0.13%
Gross Margin
67%
Oper. Margin
10%
Profit Margin
6%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1933.5-2795.0
52W High
-35.76%
52W Low
-7.11%
RSI
20.59
Rel Volume
0.72
Avg Volume
834.18K
Volume
598.2K
Perf Week
-9.77%
Perf Month
-11.99%
Perf Quarter
-20.36%
Perf Half Y
-17.86%
-
-
-
-
Beta
0.488
-
-
Volatility
65.99%, 81.72%
Prev Close
-2.34%
Price
1795.5
Change
-2.71%
4921.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 974.63 | 1.06K | 952.5 | 861.77 | 856.82 | |
| Net income per share | 68.81 | 83.11 | 66.45 | 61.5 | 41.11 | |
| Operating cash flow per share | 69.47 | 119.69 | 82.98 | 108.53 | 107.12 | |
| Free cash flow per share | 40.17 | 26.2 | 14.95 | 66.37 | 90.38 | |
| Cash per share | 137.74 | 221.18 | 199.4 | 239.75 | 294.63 | |
| Book value per share | 484.67 | 558.83 | 590.31 | 613.83 | 625.79 | |
| Tangible book value per share | 466.94 | 540.14 | 571.64 | 592.39 | 605.23 | |
| Share holders equity per share | 484.67 | 558.83 | 590.31 | 613.83 | 625.79 | |
| Interest debt per share | 1.28 | 86.62 | 85.1 | 84.82 | 85.2 | |
| Market cap | 349.53B | 291.58B | 450.59B | 329.92B | 294.16B | |
| Enterprise value | 331.06B | 273.95B | 435.37B | 310B | 267.43B | |
| P/E ratio | 40.41 | 29.2 | 56.21 | 44.46 | 59.19 | |
| Price to sales ratio | 2.85 | 2.3 | 3.92 | 3.17 | 2.84 | |
| POCF ratio | 40.03 | 20.28 | 45.01 | 25.19 | 22.71 | |
| PFCF ratio | 69.23 | 92.62 | 249.77 | 41.19 | 26.92 | |
| P/B Ratio | 5.74 | 4.34 | 6.33 | 4.45 | 3.89 | |
| PTB ratio | 5.74 | 4.34 | 6.33 | 4.45 | 3.89 | |
| EV to sales | 2.7 | 2.16 | 3.79 | 2.98 | 2.58 | |
| Enterprise value over EBITDA | 21.49 | 15.64 | 27.59 | 20.72 | 20.6 | |
| EV to operating cash flow | 37.92 | 19.05 | 43.49 | 23.67 | 20.65 | |
| EV to free cash flow | 65.57 | 87.02 | 241.33 | 38.71 | 24.47 | |
| Earnings yield | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | |
| Free cash flow yield | 0.01 | 0.01 | 0 | 0.02 | 0.04 | |
| Debt to equity | 0 | 0.15 | 0.14 | 0.14 | 0.14 | |
| Debt to assets | 0 | 0.11 | 0.11 | 0.1 | 0.1 | |
| Net debt to EBITDA | -1.2 | -1.01 | -0.96 | -1.33 | -2.06 | |
| Current ratio | 2.6 | 3.39 | 3.52 | 3.87 | 3.85 | |
| Interest coverage | 0 | 321.02 | 0 | 191.59 | 0 | |
| Income quality | 0.71 | 1.01 | 0.89 | 1.37 | 1.58 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.43 | 0.38 | 0.51 | 0.55 | 0.83 | |
| Sales general and administrative to revenue | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | |
| Capex to operating cash flow | -0.42 | -0.78 | -0.82 | -0.39 | -0.16 | |
| Capex to revenue | -0.03 | -0.09 | -0.07 | -0.05 | -0.02 | |
| Capex to depreciation | -1.2 | -3.4 | -2.24 | -1.12 | -0.46 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 866.27 | 1.02K | 939.43 | 921.6 | 760.78 | |
| ROIC | 0.14 | 0.13 | 0.1 | 0.09 | 0.06 | |
| Return on tangible assets | 0.11 | 0.11 | 0.08 | 0.08 | 0.05 | |
| Graham Net | 122 | 119.94 | 114.03 | 144.06 | 180.84 | |
| Working capital | 28.74B | 37.56B | 37.22B | 41.23B | 45.87B | |
| Tangible asset value | 58.69B | 64.89B | 68.96B | 71.49B | 73.18B | |
| Net current asset value | 27.3B | 25.96B | 25.7B | 29.56B | 33.68B | |
| Invested capital | 0 | 0.15 | 0.14 | 0.14 | 0.14 | |
| Average receivables | 15.5B | 13.85B | 12.85B | 12.75B | 11.8B | |
| Average payables | 3.14B | 3.09B | 2.84B | 3.1B | 3.4B | |
| Average inventory | 9.88B | 11.82B | 11.92B | 11.39B | 11.33B | |
| Days sales outstanding | 46.42 | 34.87 | 43.17 | 41.82 | 41.15 | |
| Days payables outstanding | 33.81 | 29.37 | 29.91 | 35.91 | 35.86 | |
| Days of inventory on hand | 119.06 | 122.6 | 125.85 | 116.46 | 122.41 | |
| Receivables turnover | 7.86 | 10.47 | 8.46 | 8.73 | 8.87 | |
| Payables turnover | 10.8 | 12.43 | 12.2 | 10.16 | 10.18 | |
| Inventory turnover | 3.07 | 2.98 | 2.9 | 3.13 | 2.98 | |
| ROE | 0.14 | 0.15 | 0.11 | 0.1 | 0.07 | |
| Capex per share | -29.3 | -93.49 | -68.03 | -42.16 | -16.75 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 234.15 | 203.77 | 224.54 | 222.59 | 242.55 | |
| Net income per share | 14.09 | 5.06 | 18.1 | 17.58 | 21.79 | |
| Operating cash flow per share | 18.28 | 18.67 | 16.03 | 16.09 | 17.01 | |
| Free cash flow per share | 18.28 | 18.67 | 16.03 | 16.09 | 17.01 | |
| Cash per share | 265.86 | 305.48 | 272.89 | 312.21 | 304.88 | |
| Book value per share | 621.97 | 625.7 | 626.56 | 644.44 | 649.83 | |
| Tangible book value per share | 601.31 | 605.15 | 606.55 | 623.89 | 629.23 | |
| Share holders equity per share | 621.97 | 625.7 | 626.56 | 644.44 | 649.83 | |
| Interest debt per share | 58.7 | 85.19 | 83 | 165.96 | 82.77 | |
| Market cap | 325.05B | 294.21B | 290.21B | 276.28B | 286.79B | |
| Enterprise value | 302.96B | 267.47B | 262.93B | 248.54B | 259.93B | |
| P/E ratio | 47.69 | 120.18 | 33.14 | 32.47 | 27.2 | |
| Price to sales ratio | 11.48 | 11.94 | 10.69 | 10.26 | 9.78 | |
| POCF ratio | 147.08 | 130.29 | 149.75 | 141.97 | 139.35 | |
| PFCF ratio | 147.08 | 130.29 | 149.75 | 141.97 | 139.35 | |
| P/B Ratio | 4.32 | 3.89 | 3.83 | 3.54 | 3.65 | |
| PTB ratio | 4.32 | 3.89 | 3.83 | 3.54 | 3.65 | |
| EV to sales | 10.7 | 10.85 | 9.68 | 9.23 | 8.86 | |
| Enterprise value over EBITDA | 97.73 | 208.96 | 79.05 | 81.89 | 69.04 | |
| EV to operating cash flow | 137.09 | 118.45 | 135.67 | 127.72 | 126.3 | |
| EV to free cash flow | 137.09 | 118.45 | 135.67 | 127.72 | 126.3 | |
| Earnings yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0.09 | 0.14 | 0.13 | 0.26 | 0.13 | |
| Debt to assets | 0.07 | 0.1 | 0.1 | 0.19 | 0.09 | |
| Net debt to EBITDA | -7.12 | -20.89 | -8.2 | -9.14 | -7.14 | |
| Current ratio | 4.03 | 3.85 | 2.36 | 2.48 | 2.58 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 1.3 | 3.69 | 0.89 | 0.91 | 0.78 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0.02 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.03 | -0.05 | 0.03 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 444.07 | 266.93 | 505.18 | 504.94 | 564.48 | |
| ROIC | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | |
| Return on tangible assets | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | |
| Graham Net | 178.25 | 191.7 | 157.13 | 209.67 | 217.48 | |
| Working capital | 44.67B | 45.87B | 36.16B | 38.99B | 40.23B | |
| Tangible asset value | 72.71B | 73.18B | 73.35B | 75.47B | 76.11B | |
| Net current asset value | 32.72B | 33.68B | 34.04B | 36.83B | 38.14B | |
| Invested capital | 0.09 | 0.14 | 0.13 | 0.26 | 0.13 | |
| Average receivables | 12.64B | 12.88B | 11.8B | 12.42B | 13.41B | |
| Average payables | 2.77B | 3.28B | 3.25B | 2.92B | 2.58B | |
| Average inventory | 10.86B | 11.28B | 11.49B | 12.1B | 12.96B | |
| Days sales outstanding | 44.76 | 42.66 | 39.51 | 43.2 | 42.63 | |
| Days payables outstanding | 30.26 | 35.6 | 32.56 | 27.74 | 23.74 | |
| Days of inventory on hand | 105.08 | 121.51 | 119.78 | 130.06 | 127.61 | |
| Receivables turnover | 2.01 | 2.11 | 2.28 | 2.08 | 2.11 | |
| Payables turnover | 2.97 | 2.53 | 2.76 | 3.24 | 3.79 | |
| Inventory turnover | 0.86 | 0.74 | 0.75 | 0.69 | 0.71 | |
| ROE | 0.02 | 0.01 | 0.03 | 0.03 | 0.03 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
4921.T Frequently Asked Questions
What is Fancl Corporation stock symbol ?
Fancl Corporation is a JP stock and trading under the symbol 4921.T
What is Fancl Corporation stock quote today ?
Fancl Corporation stock price is $1795.5 today.
Is Fancl Corporation stock public?
Yes, Fancl Corporation is a publicly traded company.
Company Profile
- Volume Average 834.18K
- Market Capitalization 239.01B
- Employee 1.28K
- CEO Mr. Kazuyuki Shimada
- Headquarters Yokohama,JP
- IPO Date 2001-01-04
-
Website
https://www.fancl.jp 
Fancl Corporation engages in the manufacture and sale of cosmetics and dietary supplements. The company provides cosmetics, quasi-drugs, nutritional supplements, and other products in Japan and internationally. It also offers germinated brown rice and kale juice products; develops and distributes undergarments and fashion goods; and distributes cosmetics and nutritional supplements. In addition, the company operates as an insurance agency. It sells its products through online and catalogue, direct store, and wholesale channels. The company was founded in 1980 and is headquartered in Yokohama, Japan.
